Superworth

Silexion Therapeutics PE ratio SLXN

Share price divided by earnings per share over the last twelve months, since 2023.

Today, Oct 23, 2026
n/m
not a meaningful number
Share price
$0.19
Oct 23, 2026

Silexion Therapeutics' PE ratio is not a meaningful number today: diluted EPS for one or more of the four quarters through 2026-06-30 is missing, so twelve months can't be added up.

It has had no meaningful PE for most of its history, so the chart below shows the earnings per share a PE divides the price by.

Earnings per share over time

A PE divides the share price by these earnings. While they were a loss or a sliver, the PE meant nothing, so this chart shows the earnings themselves.

Open the interactive chart, with overlays and comparisons

Quarter by quarter

QuarterEndedEPSOn a year earlier
Q2 FY26$5.17−88%
Q1 FY26$8.50−78%
Q3 FY25$28.80−99%
Q2 FY25$43.19−98%
Q1 FY25$38.40−98%
Q3 FY24$2742.50+160%
Q2 FY24$1978.00−78%
Q1 FY24$1843.50−56%
Q3 FY23$1053.00n/a
Q2 FY23$8842.50n/a
Q1 FY23$4144.50n/a

Against its peers

Companies in Biotechnology nearest Silexion Therapeutics' size, closest first, today.

CompanyPE ratio
SLXNSilexion Therapeuticsn/m
CRISCurisn/m
CLDICalidi Biotherapeuticsn/m
VIVSVivoSim Labs, INC.n/m
PMCBPharmaCyte Biotechn/m
LIMNLiminatus Pharman/m
AIMAIM ImmunoTechn/m
CELZCreative Medical Technologyn/m
SNTISenti Biosciencesn/m
INABIN8BIOn/m
INTSIntensity Therapeuticsn/m

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Silexion Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.